ZyVersa Therapeutics (ZVSA) Misses Q1 EPS by 22c

ZyVersa Therapeutics (NASDAQ: ZVSA) reported Q1 EPS of ($0.22).

For earnings history and earnings-related data on ZyVersa Therapeutics (ZVSA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings